Become a Member
Dark Mode
Become a Member
Uncovering Hate
WebQoof
Naukri Crisis
Scamguard
Climate Change
Raghav's Take
My Report
Opinion
Members Only
More
Brand Studio
World
Politics
Explainers
Videos
Entertainment
The Quint Lab
Sports
Gender
More
Education
Podcasts
Kaafi Real
Special Projects
Members' Opinion
Dark Mode
Become a Member
Home
Naukri Crisis
Scamguard
Uncovering Hate
Special Projects
About Us
T&C
Privacy Policy
BECOME A MEMBER
Created by potrace 1.16, written by Peter Selinger 2001-2019
FOLLOW US ON
About Us
Contact Us
Privacy Policy
ADVERTISEMENT
REMOVE AD
×
×
DGCI
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
DGCI Grants Conditional Market Approval for Covaxin & Covishield
ADVERTISEMENT
REMOVE AD
DCGI Grants Emergency Use Approval to Corbevax Vaccine for 12–18 Age Group
DGCI Grants Conditional Market Approval for Covaxin & Covishield
DGCI Gives Nod For Phase-3 Trials of Bharat Biotech’s Intranasal COVID Vaccine
Covaxin Approved for Children Between 2-18 Yrs By Expert Panel: How Safe is It?
